![Dawn Schottlandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Schottlandt
Investor Relations Contact chez
GERON CORPORATION
Profil
Dawn Schottlandt currently works at Geron Corp., as Senior VP-Corporate Affairs & Investor Relations from 2025.
Ms. Schottlandt also formerly worked at ArQule, Inc., as VP-Investor Relations & Corporate Communications from 2015 to 2018 and Chiasma, Inc., as VP-Investor Relations & Corporate Communications from 2019 to 2020.
Ms. Schottlandt received her undergraduate degree from Boston College.
Postes actifs de Dawn Schottlandt
| Sociétés | Poste | Début |
|---|---|---|
| GERON CORPORATION | Investor Relations Contact | 01/10/2025 |
Anciens postes connus de Dawn Schottlandt
| Sociétés | Poste | Fin |
|---|---|---|
| CHIASMA, INC. | Investor Relations Contact | 01/07/2020 |
| ARQULE, INC. | Investor Relations Contact | 01/01/2018 |
Formation de Dawn Schottlandt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
